Ob jec tive: To per form a ret ro spec tive sur vey of dis charge medi ca tions at a ter ti ary care psy chi at ric fa cil ity and to as sess the in ci -
C lini cal tri als of an tipsy chot ics are tra di tion ally monothera peu tic, a prac tice un re flec tive of true clini cal circum stance. In many situa tions, the con comi tant ad mini stra tion of 2 an tipsy chot ics (an tipsy chotic po lypharmacy) is used in the man age ment of in di vidu als with psy chiat ric dis or ders. Al though this con tro ver sial treat ment strat egy has been qui etly de bated for years, the lit era ture is so conspicu ously scant on the sub ject that one might guess whether it ex ists. Nev er the less, one can not deny that an tipsy chotic polyphar macy is be ing em ployed: sev eral re cent sur veys have shown that an tipsy chotic po lyphar macy has been used for up to one-fourth of out pa tients (1) and up to one-half of in patients (2) . In the out pa tient sur veys, pa tients treated with risperi done or ol an zap ine were more of ten aug mented with con ven tional an tipsy chot ics, whereas pa tients pre scribed queti apine or clo zap ine were more likely to be aug mented with a sec ond atypi cal agent. Un for tu nately, clini cal evi dence in this area is lim ited, and only a few re cent stud ies have exam ined this treat ment mo dal ity in par tial re sponse to clo zapine (3) (4) (5) .
The Ca na dian Clini cal Prac tice Guide lines for the Treat ment of Schizo phre nia sug gest that the prac tice of an tipsy chotic po lyphar macy be avoided or used "in ex cep tional cases of treat ment re sis tance" (6) . This lim ited per spec tive is un derstand able, given that evidence-based data to sup port this contro ver sial prac tice are lack ing. Nev er the less, as noted, the prac tice of an tipsy chotic po lyphar macy does oc cur. This study is a ret ro spec tive sur vey of dis charge medi ca tions at a ter ti ary care psy chi at ric fa cil ity in Can ada, un der taken to assess the in ci dence of an tipsy chotic po lyphar macy. Al though its fo cus is to ad dress the is sue of an tipsy chotic po lypharmacy, data will also be pre sented on other cate go ries of psycho tropic drugs.
Methods
This sur vey was car ried out at Riv er view Hos pi tal, a pro vincial ter ti ary care psy chi at ric teach ing hos pi tal with be tween 750 and 800 pa tients. All non geri at ric pa tients dis charged from Riv er view Hos pi tal be tween the dates of No vem ber 1, 1996 and Oc to ber 31, 1998 with the di ag no sis of schizo phrenia were eli gi ble for en try into the study. Pa tients were excluded if they did not meet the di ag nos tic cri te ria for schizo phre nia or if they had been dis charged from the in tensive care unit. Pa tients from the in ten sive care unit were excluded be cause this ward gen er ally man ages acute be hav ioural states rather than the un der ly ing Axis I dis or der. Of 492 eli gi ble pa tients dis charged from the hos pi tal dur ing the sur vey pe riod, 229 met the in clu sion cri te ria and formed the da ta base for the sur vey. We spe cifi cally chose to sur vey dis charged pa tients in an at tempt to have a more uni form study popu la tion. The use of in pa tient data would have included pa tients at vari ous stages of treat ment, re sult ing in a broad con tin uum of treat ment re sponse. The fact that our patients were dis charged is in it self an in di ca tion of treat ment suc cess and, per haps, sta bil ity.
We ac cessed the De part ment of Phar macy com puter da ta base to ret ro spec tively col lect per ti nent pa tient in for ma tion at time of dis charge. The demo graphic data re corded in cluded sex, age, di ag no sis, and du ra tion of the pres ent hos pi tali za tion. Data on dis charge medi ca tions in cluded an tipsy chot ics, an ticho liner gics, ben zo di azepines, and mood sta bi liz ers as well as the av er age dis charge dos ages for the atypi cal an tipsy chotics. Not con sid ered were "as needed" (PRN) pre scrip tions. We con ducted para met ric analy sis on con tinu ous vari ables, us ing the Stu dent's t-test as sum ing equal vari ances. To test cate gori cal vari ables for in de pend ence, the chi square or Fish er's ex act test was per formed.
Results
The rec ords of 229 pa tients with the di ag no sis of schizo phrenia were in cluded in the sur vey. The demo graphic char ac teris tics of these pa tients were com pa ra ble for the group dis charged on an tipsy chotic mono ther apy and that on antipsy chotic po lyphar macy (Ta ble 1). The mean (SD) age of the mono ther apy group was 35.7 (11.2) years, which was not sig nifi cantly dif fer ent from that of the an tipsy chotic polyphar macy group (mean 36.9, SD 10.7 years; P > 0.1). Similarly, there was no sig nifi cant dif fer ence be tween the 2 groups with re spect to the mean (SD) du ra tion of ad mis sion (mean 343.8, SD 591.9 days vs. mean 362.3, SD 592.3 days for mono ther apy-and polypharmacy-treated pa tients, re spectively; P > 0.1). Over all, more men were rep re sented in the sur vey (65%); how ever, this did not rep re sent a sig nifi cant dif fer ence be tween the group dis charged on 1 an tipsy chotic (66%) com pared with 2 an tipsy chot ics (60%; P > 0.1).
Our sur vey found that 166 (72.5%) of the pa tients dis charged from our fa cil ity were pre scribed 1 an tipsy chotic. The remain ing 63 (27.5%) pa tients were dis charged on an an tipsychotic po lyphar macy regi men (Ta ble 1). In ad di tion, the an tipsy chotic po lyphar macy group re ceived sig nifi cantly more dis charge medi ca tions than could be ex clu sively accounted for by the ad di tional an tipsy chot ics (mean 3.5, SD 1.1 vs. mean 2.2, SD 1.0; P < 0.05). In this re gard, sig nificantly more pa tients in the an tipsy chotic po lyphar macy group (55.6%) re ceived an an ti cho liner gic medi ca tion, compared with pa tients dis charged on mono ther apy (36.8%; P < 0.01). No sig nifi cant dif fer ences be tween the 2 groups were ob served with re spect to the pro por tion of pa tients dis charged on ben zo di azepines, mood sta bi liz ers, or an ti de pres sants (P > 0.1).
Ta ble 2 lists the vari ous an tipsy chot ics that the pa tients were pre scribed at dis charge and in cludes the mean daily dos ages for the atypi cal an tipsy chot ics. Of the 50 pa tients dis charged on clo zap ine, 11 pa tients re ceived a sec ond an tipsy chotic. The mean (SD) daily pre scribed dis charge dos age of clo zapine in the mono ther apy group was 368 (172) mg. Al though the pre scribed dis charge dos age of clo zap ine was re duced when co pre scribed with a sec ond an tipsy chotic, it did not reach sta tis ti cal sig nifi cance (mean 320, SD 132 mg; P > 0.1). In the case of pa tients pre scribed ol an zap ine at discharge, 19 of 61 (31%) also re ceived a pre scrip tion for a second an tipsy chotic. As with clo zap ine, there was no sig nifi cant dif fer ence in dos age be tween the pa tients discharged on mono ther apy and the po lyphar macy group (mean 16.9, SD 7.4 mg vs. mean 15.7, SD 6.2 mg, re spec tively; P > 0.1). Forty-three per cent of the pa tients (20 of 46, Ta ble 2) dis charged with a pre scrip tion for risperi done left the hos pi tal on an an tipsy chotic po lyphar macy regi men. In this case, there was a sta tis ti cal dif fer ence ob served in dos ages be tween the pa tients dis charged on mono ther apy and the po lyphar macy group (mean 6.0, SD 2.4 vs. mean 4.6, SD 1.9 mg, re spectively; P = 0.03). Only 3 pa tients were dis charged on quetiapine: 2 as mono ther apy and 1 in com bi na tion with an other an tipsy chotic. Al though the daily dos age of queti apine used as mono ther apy (mean 255, SD 106 mg) was much lower than when used in com bi na tion (600 mg), we can not ver ify sta tis ti cal sig nifi cance due to the small sam ple (n = 3). Apart from the atypi cal an tipsy chot ics, pa tients were also discharged on con ven tional agents (Ta ble 2).
Pa tients dis charged on an tipsy chotic mono ther apy in cluded 35 pa tients pre scribed an oral con ven tional an tipsy chotic and 22 pre scribed a de pot an tipsy chotic. Taken to gether, this repre sents 25% of the study popu la tion. Fur ther, oral con ventional and de pot agents con trib uted to 51 and 7 of the an tipsy chotic po lyphar macy regi mens, re spec tively.
Ta ble 2 also de tails the use of an ti cho liner gic medi ca tion between the 2 groups. In this sub group analy sis, we did not note any sta tis ti cal dif fer ence in the use of an ti cho liner gics between the an tipsy chotic mono ther apy and po lyphar macy groups. In all cases, ex cept for pa tients dis charged on a polyphar macy regi men that in cluded ol an zap ine, the P-value is greater than 0.1. In the case of the olanzapine-treated pa tients, the P-value ap proaches, but does not at tain, sig nifi cance (P = 0.08).
Ta ble 3 gives de tails of the spe cific dis charge po lyphar macy com bi na tions. The most com mon regi men con sisted of 2 conven tional an tipsy chot ics (oral or de pot). Of the 20 pa tients dis charged on 2 con ven tional agents, 15 (75%) were also prescribed an an ti cho liner gic medi ca tion. The sec ond most common an tipsy chotic po lyphar macy regi men in cluded the con comi tant use of ol an zap ine and an oral con ven tional agent. In this case, the mean daily dos age of ol an zap ine was 14.9 (SD 6.3) mg. Of these pa tients, 6 (46%) also re ceived a pre scrip tion for an an ti cho liner gic. Aside from the use of olan zap ine with con ven tional agents, it was also co pre scribed with clo zap ine (1 pa tient), risperi done (2 pa tients), and de pot an tipsy chot ics (3 pa tients). In these in stances, the mean daily dos ages of ol an zap ine were 20, 20, and 15 (SD 8.7) mg respec tively (Ta ble 3). The third most fre quent po lyphar macy com bi na tion was risperi done with an oral con ven tional agent. The mean daily dos age of risperi done in this case was 5.0 (SD 1.2) mg, and in 90% of the cases, the pa tients were dis charged with an an ti cho liner gic. Risperi done was also co pre scribed with clo zap ine (5 pa tients) at 3.0 (SD 2.0) mg daily, ol an zapine (2 pa tients) at 4.0 (SD 2.8) mg daily, and de pot an tipsychot ics (3 pa tients) at 6.0 (SD 2.0) mg daily. Eleven pa tients were dis charged on clo zap ine com bined with a sec ond antipsy chotic: 5 with risperi done, 1 with ol an zap ine, and 5 with an oral con ven tional agent. The mean daily dos ages of clozap ine were 355 (SD 184) mg, 300 mg, and 290 (SD 82) mg re spec tively. Of these 11 pa tients, only 1 left the hos pi tal with a pre scrip tion for an an ti cho liner gic agent. In this case, the patient re ceived clo zap ine com bined with an oral con ven tional agent.
Discussion
The pri mary find ing of this study was that 27.5% of pa tients dis charged from our fa cil ity left on an an tipsy chotic polyphar macy regi men. This rela tively high oc cur rence may at first seem dif fi cult to jus tify, since it is a prac tice not embraced by ei ther the Work ing Group for the Ca na dian Psy chiat ric As so cia tion or The Ca na dian Al li ance for Re search on Schizo phre nia: their Clini cal Prac tice Guide lines for the Treat ment of Schizo phre nia rec om mend that an tipsy chotic po lyphar macy ei ther be avoided or used "in ex cep tional cases of treat ment re sis tance" (6). Fur ther, there is lit tle documented evi dence that any bene fit is de rived from the use of 2 an tipsy chot ics rather than 1 (3-5), and some of the stud ies that have shown a fa vour able re sult with com bi na tions suf fer from se ri ous meth odo logi cal weak nesses (7-9). In any event, the ex is tence of an tipsy chotic po lyphar macy in clini cal practice is cer tainly not a re cent phe nome non. In pre vi ous prescrip tion sur veys dat ing as far back as 1969, the in ci dence of an tipsy chotic po lyphar macy ranges from ap proxi mately 10% to 69% (10) (11) (12) (13) (14) (15) . Com par ing these stud ies is dif fi cult, ow ing to dif fer ences in popu la tions stud ied, type of care (hos pi taliza tion, day-hospitalization, out pa tient), age range of the patients, and pro por tion of chronic pa tients. It does not, how ever, ne gate the fact this prac tice has pre vailed for years.
In our sur vey, the mean number of daily psy cho tropic medica tions per pa tient (ex clud ing PRN drugs) was 2.2 (SD 1.0) and 3.5 (SD 1.1) (P < 0.05) for in di vidu als dis charged on antipsy chotic mono ther apy and po lyphar macy, re spec tively. Not con sid er ing an tipsy chotic po lyphar macy, Voi rol and oth ers, re ported a mean number of 3.2 drugs daily per pa tient (ex clud ing PRNs) dur ing the pe riod of Janu ary 1, 1989, to De cem ber 31, 1989 , for in pa tients at a psy chi at ric uni ver sity hos pi tal in Swit zer land (16) . This Swiss study was de signed with a meth odo logi cal ap proach simi lar to that of Schmidt and oth ers, who ob served a mean value of 2.6 psy cho tropic medi ca tions daily per pa tient dur ing a 2-year pe riod (April 1, 1979, to March 31, 1981) at a psy chi at ric uni ver sity hos pi tal in Ber lin (17) . Follow-up data on the lat ter study re ported mean val ues of 3.25 in 1981 and 3.0 in 1984 (18) . The sig nificantly greater mean number of dis charge medi ca tions seen in our po lyphar macy group can not be ex plained solely by the ad di tion of the sec ond an tipsy chotic but rather by the expected greater use of an ti cho liner gic agents: 55.6% of the patients leav ing hos pi tal on an an tipsy chotic po lyphar macy regi men re ceived a pre scrip tion for an an ti cho liner gic agent, com pared with 36.8% dis charged on an tipsy chotic monother apy (P < 0.01). This is likely due to the preva lent use of con ven tional agents found in the an tipsy chotic po lypharmacy regi mens. In this re gard, 55 of the 63 an tipsy chotic polyphar macy treat ment regi mens in clude a con ven tional agent (Ta ble 3). The use of ben zo di azepines, mood sta bi liz ers, and an ti de pres sants did not con trib ute to the sig nifi cant dif ference in the to tal number of dis charge medi ca tions ob served in the po lyphar macy group.
The over all use of an ti cho liner gics in our study was 42% (96 of 229 pa tients, Ta ble 1). This fig ure is higher than the 31.7% ob served by Voi rol and oth ers in Swit zer land (16) , but lower than the 51% and 53% in ci dence re ported in a Bir ming ham and a Ber lin psy chi at ric hos pi tal re spec tively (17, 19) . Without clini cal in for ma tion re gard ing side ef fects and du ra tion of an tipsy chotic treat ment, it is not pos si ble to as sess whether the use of an ti cho liner gic agents in our pa tient popu la tion was ex ces sive. None the less, apart from ques tions of mem ory impair ment (20) , an ti cho liner gic ther apy ought to be re evaluated, given that sev eral stud ies have shown that up to 80% of pa tients with drawn from an ti park in sonian drugs have no recur rence of ex tra py ra mi dal symp toms (21-23). Fur ther, a sig nifi cant re la tion has been dem on strated be tween tar dive dyski ne sia and the amount of an ti park in sonian medi ca tion pre scribed for pa tients on long-term medi ca tion (24) . While Kane and Smith con cluded that there was cur rently in suf ficient clini cal data to con firm this re la tion, they also em phasized the im por tance of the ju di cious use of an ti cho liner gics (25) .
Of dis charged pa tients, 22% left our hos pi tal with a pre scription for clo zap ine (50 of 229 pa tients, Ta ble 2). This per centage is high when com pared with pre vi ous in pa tient sur veys wherein the in ci dence of pa tients re ceiv ing clo zap ine ranged from 9.4% to 13% (17, 26) . This higher in ci dence of pa tients pre scribed clo zap ine may re flect a more se verely ill pa tient popu la tion at our in sti tu tion. In our study, there was no signifi cant dif fer ence in dos age when clo zap ine was pre scribed alone or in com bi na tion with a sec ond an tipsy chotic (mean 368, SD 172 mg daily vs. mean 320, SD 132 mg daily, re spectively; P > 0.1). These dos ages are com pa ra ble to the mean daily dos ages re ported by Voi rol and oth ers (328 mg daily), as well as to those of a double-blind study of risperi done vs. clo zap ine con ducted in Lau sanne and other Swiss cen tres (291 mg daily) (16, 27) . On the other hand, our re ported dosages of clo zap ine are higher than those re ported by Schmidt and oth ers at a uni ver sity psy chi at ric hos pi tal in Ber lin (258.9 mg daily) (18) .
Pa tients dis charged on risperi done or ol an zap ine made up 20% (46 of 229 pa tients, Ta ble 2) and 27% (61 of 229 patients, Ta ble 2) of the study popu la tion, re spec tively. Un fortu nately, we are un able to make any com pari sons to other in ves ti ga tions, be cause ear lier stud ies were con ducted prior to the in tro duc tion of these agents onto the mar ket. In any event, the mean dis charge dos ages ob served for these agents are in keep ing with the dos age guide lines rec om mended by the re spec tive manu fac tur ers. As was the case for clo zap ine, no sta tis ti cally sig nifi cant dif fer ence in dos age was ob served when ol an zap ine was pre scribed alone or in com bi na tion with a sec ond an tipsy chotic (Ta ble 2). There was, how ever, a sta tis ti cally sig nifi cant re duc tion in risperi done dos age when it was co pre scribed with an other an tipsy chotic. Fi nally, there was no sig nifi cant in crease in the use of an ti cho liner gics for pa tients re ceiv ing these agents in a po lyphar macy regi men, al though a trend to ward sig nifi cance was no ticed in the ol anzap ine po lyphar macy group (Ta ble 2). This may in part be explained by the rela tively high preva lence of ol an zap ine co pre scribed with con ven tional agents that pre suma bly have greater D 2 re cep tor block ade (Ta ble 3).
As al ready in di cated, 27.5% of the pa tients dis charged from our fa cil ity were on an tipsy chotic po lyphar macy regi mens. Not sur pris ingly, each of the atypi cal agents had been co prescribed with con ven tional agents (Ta ble 3). Pre suma bly, this strat egy was an at tempt to in crease D 2 re cep tor an tago nism or to of fer com ple men tary ef fects at other re cep tor sites (no ta bly the α-a dre ne rgic, mus car inic cho liner gic, and his ta minic recep tor sites). Of pa tients co pre scribed an oral con ven tional agent with risperi done, 9 (90%) were also re ceiv ing a prescrip tion for an an ti cho liner gic. This is con sid era bly higher than the preva lence ob served for pa tients dis charged on a regi men com pris ing ei ther 2 con ven tional agents (75%) or olan zap ine in com bi na tion with an oral con ven tional agent (46.2%, Ta ble 3). It is con ceiv able that the mean dis charge dos age of risperi done (5.0, SD 1.15 mg daily) in com bi na tion with a con ven tional agent is too high and re sults in an increased D 2 re cep tor block ade. Sup port ing this sup po si tion is the ob ser va tion that no an ti cho liner gic agents were re quired when risperi done was co pre scribed with clo zap ine at a mean dos age of 3.0 (SD 2.0) mg daily (Ta ble 3).
One pa tient was dis charged on an an tipsy chotic po lypharmacy regi men con sist ing of clo zap ine and ol an zap ine. Consid er ing that both of these agents are diben zo di azepines, jus ti fi ca tion for this par ticu lar com bi na tion is dif fi cult. Without strong clini cal evi dence for an tipsy chotic po lyphar macy, logic and per haps in tui tion, would dic tate that a ra tional approach to this treat ment strat egy should con sist of us ing antipsy chot ics from 2 dif fer ent chemi cal classes. Be cause the clini cal de tails of this par ticu lar pa tient are, how ever, unknown, judge ment must be stayed. It may be that this pa tient failed pre vi ous, more ra tional, an tipsy chotic po lyphar macy regi mens.
Cur rently ac cepted in di ca tions for an tipsy chotic po lypharmacy in clude over lap ping strate gies (28) . For ex am ple, it is con sid ered ac cept able to com bine an tipsy chot ics for the short term when a pa tient is be ing switched from one agent to another. Simi larly, com bin ing an oral agent with a de pot injecta ble would seem rea son able to ini ti ate long-term main te nance treat ment with the de pot agent. Al though control of agi ta tion has of ten been cited as a rea son for an tipsychotic po lyphar macy (29) , its ef fi cacy has not been vali dated by ear lier double-blind stud ies (7, 30) . In ad di tion, the Ca nadian Clini cal Prac tice Guide lines for the Treat ment of Schizo phre nia rec om mend sin gle test-dose pro ce dures for treat ing the se verely ag gres sive or agi tated pa tient (6) . If there are other jus ti fi able in di ca tions for an tipsy chotic po lypharmacy, they have been nei ther in ves ti gated nor vali dated.
Since clini cal data were not col lected in this study, it is dif ficult to as sess whether the use of an tipsy chotic po lyphar macy was ra tional or ir ra tional. In all prob abil ity, both sce nar ios are rep re sented. The ques tion then be comes, What con sti tutes rational an tipsy chotic po lyphar macy? Apart from the ac cepted strate gies dis cussed above, poor treat ment re sponse to various tri als of an tipsy chotic mono ther apy ap pears to be a rational in di ca tion for po lyphar macy. Co in ci den tally, the in ci dence of in ade quate treat ment re sponse has been re ported to be as high as 25% (31,32)-a fig ure that par al lels the propor tion of our pa tients dis charged on an tipsy chotic po lypharmacy. If we agree that in ade quate treat ment re sponse jus ti fies the em ploy ment of an tipsy chotic po lyphar macy, then we need to ad dress how best to se lect an tipsy chotic com bi nations. Given the long ex is tence and preva lence of this treatment mo dal ity, it is al most in con ceiv able that the lit era ture se ri ously lacks stud ies, or even an ec do tal re ports (3) (4) (5) . Stephen Stahl has re ferred to this phe nome non as "Psy chia try's dirty lit tle se cret" (33) . In any event, un til clini cal tri als have been per formed on an tipsy chotic com bi na tions, it is criti cal that any com bi na tion or aug men ta tion strate gies be grounded in a ra tional ap pli ca tion of phar ma co dy namic and phar macoki netic prin ci ples (34, 35) . Be cause each an tipsy chotic displays a unique phar ma co dy namic and phar ma coki netic pro file, it be comes nec es sary to con sider the con tri bu tions of each agent when 2 an tipsy chot ics are com bined. Fur ther, when the re sults of this sur vey are in ter preted, it should be kept in mind that the pa tients were dis charged from a longterm fa cil ity; it may be that the pre scrib ing pat terns de scribed here re flect treat ing a sub group of pa tients with a more chronic, treatment-resistant form of schizo phre nia.
Conclusion
The main find ing of this sur vey was that 27.5% of our discharged pa tients di ag nosed with schizo phre nia left our fa cility on an an tipsy chotic po lyphar macy regi men. Al though the over all use of an ti cho liner gic agents was sig nifi cantly greater in the po lyphar macy group, sub group analy sis of the vari ous an tipsy chotic com bi na tions found no dif fer ence in the use of an ti cho liner gics com pared with the mono ther apy group. Of the atypi cal agents, only risperi done showed a sta tis ti cally sig nifi cant re duc tion in dos age when co pre scribed with a second an tipsy chotic.
We share the opin ion of Dia mond and oth ers, as well as Edwards and Ku mar: pre scrib ing sur veys form a use ful part of medi cal audit and are help ful in im prov ing pre scrib ing hab its (19, 36) . We re port our find ings not only to raise aware ness regard ing the preva lence of an tipsy chotic po lyphar macy but also in the hope of stimu lat ing dis cus sion con cern ing its appro pri ate use. Un ques tiona bly, this con tro ver sial treat ment strat egy-the prod uct of sub jec tive clini cal im pres sion rather than of con trolled clini cal tri als, will per sist in clini cal practice. That said, ra tional phar ma co dy namic and phar ma cokinetic un der stand ing of drug ac tion, not sub jec tive clini cal im pres sion, should serve as the ba sis of this treat ment mo dality. Un til fur ther clini cal tri als have been per formed, cli nicians may bene fit from the de vel op ment of guide lines
